Oral Antiviral Successfully Blocks SARS-CoV-2 Transmission

In COVID-19, Latest News by Precision Vaccinations

A new study found treating a SARS-CoV-2 infection with a new antiviral drug, MK-4482/EIDD-2801 or Molnupiravir, completely suppresses virus transmission within 24 hours.
Researchers in the Institute for Biomedical Sciences at Georgia State University, led by Dr. Richard Plemper, Distinguished University Professor at Georgia State, originally discovered that the drug is potent against influenza viruses.

Read More